Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes

OBJECTIVE: We have previously reported evidence of an inverse association between a urinary F(2)-isoprostane and type 2 diabetes risk in a pilot case-control study nested within the Insulin Resistance Atherosclerosis Study (IRAS). Here, we report the results from the study extended to the entire IRA...

Descripción completa

Detalles Bibliográficos
Autores principales: Il'yasova, Dora, Spasojevic, Ivan, Base, Karel, Zhang, Haoyue, Wang, Frances, Young, Sarah P., Millington, David S., D’Agostino, Ralph B., Wagenknecht, Lynne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241306/
https://www.ncbi.nlm.nih.gov/pubmed/22100959
http://dx.doi.org/10.2337/dc11-1502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241306/
https://www.ncbi.nlm.nih.gov/pubmed/22100959
http://dx.doi.org/10.2337/dc11-1502

Ejemplares similares